Q3 2024 · 13F-HR
NVP Associates, LLCholdings as filed
Filed 2024-11-12 · accession 0001104659-24-116813
$176.1M
Reported value
8
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 55287L101 | MBX | MBX BIOSCIENCES INC | $55.5M | 31.5% | 2,136,335 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $31.1M | 17.7% | 1,838,482 | Common | SOLE |
| 87427V103 | TALK | TALKSPACE INC | $30.7M | 17.4% | 14,702,972 | Common | SOLE |
| 23834J201 | DAVE | DAVE INC | $23.3M | 13.2% | 582,675 | Common | SOLE |
| 902685106 | 7WH | UDEMY INC | $23.2M | 13.2% | 3,114,732 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR TECHNOLOGIES INC | $8.4M | 4.76% | 4,189,562 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE HOLD INC | $4.0M | 2.26% | 2,943,522 | Common | SOLE |
| 25401N408 | — | DIGITAL BRANDS GROUP INC | $214 | 0.00% | 636 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.